NASDAQ NMS - GLOBAL MARKET · CDNA
-4.32% · -$1.13 · Vol 735.9K
CareDx Inc

CareDx Inc

Biotechnology
$25.05

Veridion Score

Refresh
Score snapshot refresh in progress
Veridion Score History · 90D

Composite trend over time

HISTORY REFRESH IN PROGRESS
REFRESHES DAILY
AI Analysis
Sovereign

Why is CDNA moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About CareDx Inc
SERVICES-MEDICAL LABORATORIES
Listed since
2014
Employees
765
Country
US

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$26.23
Day high
$26.78
Day low
$24.90
Previous close
$26.18
52W high
$26.78
-6.46% from high
52W low
$23.35
50% of range
Market cap
$1.4B
EPS
$-0.2700
Shares out
51.7M
Volume
735.9K
VWAP
$25.37
Price history computed in-house
1W
+7.01%
SMA 50 $24.21 · above
SMA 200 $24.21 · above
52W position 50%
Veridion warehouse edge

Warehouse intelligence for CDNA.

Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.
Data ledger
Quote and day range
Refresh interval: 30 seconds
Source: Market data
Veridion Score
Coverage building
Chart and risk context
Daily bars with no missing-bar fill
Source: Market data
News and filings
Refresh intervals shown inside each panel
Source: Market news and federal filings
Financials
Statements refresh in progress
SEC Form 4 ledger

CDNA insider activity

CareDx Inc

Score
Coverage building
Pressure
Net selling
Filings
41
Buys / sells
4 / 37
Net value
-$5.5M
Insiders
11
Named filers
VH
Valantine Hannah
Insider
Leadership
HJ
Hanna John Walter JR
Insider
Leadership
NA
Novack Jeffrey Adam
Insider
Leadership
Cluster

No multi-insider buying cluster in the last 90 days

Net pressure

Net selling: -$5.5M across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Filing dateTrade dateInsiderTitleTypePriceQtyOwnedValueReceipt
2026-06-162026-06-15Valantine HannahInsidersell$23.1112,10336,686$280KSEC Form 4
2026-06-152026-06-11Hanna John Walter JRInsidersell$24.0221,998649,642$528KSEC Form 4
2026-06-092026-06-06Novack Jeffrey AdamInsidersell$21.951,292112,632$28KSEC Form 4
2026-06-082026-06-04Hanna John Walter JRInsidersell$24.004,835671,640$116KSEC Form 4
2026-05-182026-05-15TORRES ARTHUR AInsidersell$19.896,48438,665$129KSEC Form 4
Full Form 4 history requires Sovereign

Showing 5 recent rows. Sovereign unlocks 36 additional rows, full sorting, and the named-filer history.

Upgrade to Sovereign · $25/mo
Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology
Congress · 90D
Congress filing snapshot refresh in progress
Federal contracts

CDNA contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for CDNA in this window.
Lobbying spend

CDNA lobbying filings, year to date.

Registered lobbying filings matched to CareDx Inc.

$385.0K
Refresh interval: 12hSource: LDA disclosure filings
Medicare/MedicaidMedicare/Medicaid Health Issues
Filing
$140.0K
CAREDX INC.

CAREDX, INC.

Apr 20, 2026
Filing
$110.0K
CAREDX INC.

CAREDX, INC.

Jan 20, 2026
Filing
$60.0K
CAREDX INC.

TODD STRATEGY GROUP

Apr 20, 2026
Latest news · CDNA
Refresh interval: 5 minutes · Source: Market news insights
News snapshot refresh in progress
Analyst ratings
Sovereign unlock shows live analyst consensus for CDNA.
Options
Sovereign unlock shows live options positioning for CDNA.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.